Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
George S. Laszlo, Brenda M. Sandmaier, Allie R. Kehret, Johnnie J. Orozco, Donald K. Hamlin, Shannon L. Dexter, Sheryl Y. T. Lim, Frances M. Cole, Jenny Huo, D. Scott Wilbur & Roland B. Walter. (2023) [211At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies. Leukemia & Lymphoma 64:7, pages 1335-1339.
Read now
Read now
Roger W. Howell. (2023) Advancements in the use of Auger electrons in science and medicine during the period 2015–2019. International Journal of Radiation Biology 99:1, pages 2-27.
Read now
Read now
Roland B Walter. (2022) Where do we stand with radioimmunotherapy for acute myeloid leukemia?. Expert Opinion on Biological Therapy 22:5, pages 555-561.
Read now
Read now
Articles from other publishers (27)
Wan Su Yun, Jeongrae Kim, Dong-Kwon Lim, Dong-Hwee Kim, Seong Ik Jeon & Kwangmeyung Kim. (2023) Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems. Nanomaterials 13:15, pages 2225.
Crossref
Crossref
Simon H. Zientek, Stephen Thompson, Selena Milicevic Sephton & Franklin I. Aigbirhio. (2023) The inverse electron demand Diels–Alder cycloaddition with carbon‐11 and fluorine‐18: A gateway to pretargeted imaging across the blood–brain barrier. Journal of Labelled Compounds and Radiopharmaceuticals 66:9, pages 249-268.
Crossref
Crossref
Anna Julie Kjøl Tornes, Vilde Yuli Stenberg, Roy Hartvig Larsen, Øyvind Sverre Bruland, Mona-Elisabeth Revheim & Asta Juzeniene. (2022) Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma. Frontiers in Medicine 9.
Crossref
Crossref
Charles A. Maitz, Samantha Delaney, Brendon E. Cook, Afaf R. Genady, Rebecca Hoerres, Marina Kuchuk, Georgios Makris, John F. Valliant, Saman Sadeghi, Jason S. Lewis, Heather M. Hennkens, Jeffrey N. Bryan & Brian M. Zeglis. (2022) Pretargeted PET of Osteodestructive Lesions in Dogs. Molecular Pharmaceutics 19:9, pages 3153-3162.
Crossref
Crossref
Shailendra K. Gautam, Vipin Dalal, Maneesh Jain & Surinder K. Batra. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
437
461
.
Federica Orsini, Sara Mazzarri, Erinda Puta, Federica Guidoccio, Alice Lorenzoni & Giuliano Mariani. 2020. Nuclear Oncology. Nuclear Oncology
1
18
.
Federica Orsini, Sara Mazzarri, Erinda Puta, Federica Guidoccio, Alice Lorenzoni & Giuliano Mariani. 2022. Nuclear Oncology. Nuclear Oncology
133
149
.
Murat Tuncel & Pınar Ö. Kıratlı. 2022. Radionuclide Therapy. Radionuclide Therapy
363
373
.
Meltem Ocak. 2022. Radionuclide Therapy. Radionuclide Therapy
3
17
.
Julie Rousseau, Joseph Lau & François Bénard. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology
297
345
.
Majid Assadi & Ali Gholamrezanezhad. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology
281
295
.
Zbynek Novy, Jiri Janousek, Pavel Barta, Milos Petrik, Marian Hajduch & Frantisek Trejtnar. (2021) Preclinical evaluation of anti‐VEGFR2 monoclonal antibody ramucirumab labelled with zirconium‐89 for tumour imaging. Journal of Labelled Compounds and Radiopharmaceuticals 64:7, pages 262-270.
Crossref
Crossref
Betül Altunay, Agnieszka Morgenroth, Mohsen Beheshti, Andreas Vogg, Nicholas C. L. Wong, Hong Hoi Ting, Hans-Jürgen Biersack, Elmar Stickeler & Felix M. Mottaghy. (2020) HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. European Journal of Nuclear Medicine and Molecular Imaging 48:5, pages 1371-1389.
Crossref
Crossref
Tina Briolay, Tacien Petithomme, Morgane Fouet, Nelly Nguyen-Pham, Christophe Blanquart & Nicolas Boisgerault. (2021) Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Molecular Cancer 20:1.
Crossref
Crossref
Alice D'Onofrio, Lurdes Gano, Rita Melo, Filipa Mendes, Maria Cristina Oliveira, Thibaut Denoël, Niklaus Schaefer, David Viertl, Julie Fierle, George Coukos, Steven Dunn, John O. Prior & António Paulo. (2021) Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies. European Journal of Pharmaceutics and Biopharmaceutics 158, pages 233-244.
Crossref
Crossref
Maryline G. Ferrier, Yawen Li, Ming‐Kuan Chyan, Roger Wong, Lily Li, Sarah Spreckelmeyer, Donald K. Hamlin, Tara Mastren, Michael E. Fassbender, Chris Orvig & D. Scott Wilbur. (2020) Thorium chelators for targeted alpha therapy: Rapid chelation of thorium‐226. Journal of Labelled Compounds and Radiopharmaceuticals 63:12, pages 502-516.
Crossref
Crossref
Xudong Wang, Wenzong Ma, Weihao Liu, Huan Ma, Yuanyou Yang, Yugang Wang, Ning Liu & Gen Yang. (2020) Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs. Journal of Radiation Research 61:5, pages 684-690.
Crossref
Crossref
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann & George Coukos. (2020) Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. The Lancet Oncology 21:9, pages e419-e430.
Crossref
Crossref
Annamaria Sandomenico, Jwala P. Sivaccumar & Menotti Ruvo. (2020) Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments. International Journal of Molecular Sciences 21:17, pages 6324.
Crossref
Crossref
Falco Reissig, Kristof Zarschler, René Hübner, Hans‐Jürgen Pietzsch, Klaus Kopka & Constantin Mamat. (2020) Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy. ChemistryOpen 9:8, pages 797-805.
Crossref
Crossref
Jeong A. Park & Nai-Kong V. Cheung. (2020) Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of Clinical Oncology 38:16, pages 1836-1848.
Crossref
Crossref
Judit Fazekas-Singer, Josef Singer & Erika Jensen-Jarolim. (2020) Precision medicine in clinical oncology: the journey from IgG antibody to IgE. Current Opinion in Allergy & Clinical Immunology 20:3, pages 282-289.
Crossref
Crossref
Maryline G. Ferrier & Valery Radchenko. (2019) An Appendix of Radionuclides Used in Targeted Alpha Therapy. Journal of Medical Imaging and Radiation Sciences 50:4, pages S58-S65.
Crossref
Crossref
Dobeen Hwang, Kohei Tsuji, HaJeung Park, Terrence R. BurkeJr.Jr. & Christoph Rader. (2019) Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody–Drug Conjugates. Bioconjugate Chemistry 30:11, pages 2889-2896.
Crossref
Crossref
Maryline G. Ferrier, Valery Radchenko & D. Scott Wilbur. (2019) Radiochemical aspects of alpha emitting radionuclides for medical application. Radiochimica Acta 107:9-11, pages 1065-1085.
Crossref
Crossref
Wen-Ting K. Tsai & Anna M. Wu. (2018) Aligning physics and physiology: Engineering antibodies for radionuclide delivery. Journal of Labelled Compounds and Radiopharmaceuticals 61:9, pages 693-714.
Crossref
Crossref
Mahsa Eskian, MirHojjat Khorasanizadeh, Pier L Zinzani & Nima Rezaei. (2018) Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy 10:8, pages 699-711.
Crossref
Crossref